Skip to main content

Table 1 Socio-demographic characteristics of the study population (n = 311)

From: Prevalence and determinants of selected cardio-metabolic risk factors among people living with HIV/AIDS and receiving care in the South West Regional Hospitals of Cameroon: a cross-sectional study

Characteristic

Total (n = 311)

Females (n = 261)

Males (n = 50)

P*

Age in years, mean (± SD)

43.4 (± 10.6)

41.7 (± 10.6)

45.9 (± 10.4)

0.010

Age, years

   

0.220

 ≤ 45

197 (63.3%)

169 (85.8%)

28 (14.2%)

 

 > 45

114 (36.7%)

92 (80.7%)

22 (19.3%)

 

BMI, mean (kg/m2)

25.0 (± 4.7)

25.2 (± 4.8)

23.8 (± 3.7)

0.047

BMI categories (kg/m2)

   

0.580a

 < 25

182 (58.5%)

158 (82.4%)

32 (17.6%)

 

 ≥ 25 to < 30

84 (27%)

70 (83.3%)

14 (16.7%)

 

 ≥ 30

45 (14.5%)

41 (91.1%)

4 (8.9%)

 

HAART combinations (n = 302)

   

0.128

 AZT + 3TC + EFV

10 (3.3%)

7 (70%)

3 (30%)

 

 AZT + 3TC + NVP

189 (62.6%)

164 (86.8%)

25 (13.2%)

 

 AZT + 3TC + NVP + TFV

1 (0.3%)

1 (100%)

0 (0%)

 

 TFV + 3TC + EFV

71 (23.5%)

54 (76.1%)

17 (23.9%)

 

 TFV + 3TC + LPV + IDV

1 (0.3%)

1 (100%)

0 (0%)

 

 TFV + 3TC + NVP

28 (9.3%)

25 (89.3%)

3 (10.7%)

 

 D4T + 3TC + NVP

2 (0.7%)

1 (50%)

1 (50%)

 

CD4 count, mean (cell/mm3)

470.5 (± 260)

484.4 (± 266.8)

398 (± 208.5)

0.032

CD4 count, cell/mm3

   

0.060

 CD4 count ≤ 350

95 (30.5%)

74 (77.9%)

21 (22.1%)

 

 CD4 count > 350

216 (69.5%)

187 (86.6%)

29 (13.4%)

 
  1. AZT zidovudine, 3TC lamivudine, EFV efavirenze, TDF tenofovir, IDV indinavir, D4T stavudine, LPV lopinavir, BMI body mass index, SD standard deviation
  2. * P value for comparison between males and females; data are presented as mean ± SD or counts (%)
  3. aP value after fisher’s exact test